Studies: Primärtherapie mit Radiochemotherapie +/- CetuximabID TrialDELOS IIEudraCT number2006-006091-38Clinicaltrials.gov identifierNCT00508664DescriptionRandomised phase II screening study to be used in an TP/TPF-chemotherapy (short induction) before TP/TPF-induction, radiotherapy with or without cetuximab in the primary therapy of the only by lyryngectomy operable carcinoma of the larynx/hypopharynx StatusactiveDisease
Treatment arms
SponsorUniversitätsklinikum Leipzig AöRLiebigstraße 18 04103 Leipzig Germany Coordinating investigatorNo dataPrincipal investigator
Study nurseNo data |
|